90Y-DTPA-besilesomab

N/A

Report date: 2025/09/11 11:16:21

Base Information

Drug Name90Y-DTPA-besilesomab
Drug Alias NameY-90-anti-CD6690Y-besilesomabYttrium-90 besilesomab(Telix Pharmaceuticals)Yttrium-90 labelled anti-CD66 monoclonal antibody(Telix Pharmaceuticals)yttrium Y 90 anti-CD66 monoclonal antibody BW 250/183 +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murineRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionAnti-NCA-95
TargetsNon specific cross-reacting antigen 95
Therapy Area/IndicationsPlasmacytomaMultiple MyelomaNeoplasms, Plasma Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTelix Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Southampton
Inactive CompaniesN/A
Active IndicationsNeoplasms, Plasma Cell
Inactive IndicationsPlasmacytomaMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A